1-3 of 3
Ravi Vij, MD MBBS
Close
Sort by
Journal Articles

Treatment Patterns and Associated Outcomes in Patients with Relapsed or Refractory Multiple Myeloma in the US and Non-US Countries: Findings from Preamble

Ravi Vij, MD MBBS, Clara Chen, PhD BS, MS, Sergey Popov, Brian Durie, Gordon Cook, MD PhD, Teresa Zyczynski, PharmD, MPH, MBA, BSPharm, Catherine Davis, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3123.
https://doi.org/10.1182/blood.V130.Suppl_1.3123.3123
Published: 2017
Journal Articles

Healthcare Resource Utilization and Costs Associated with Different Treatment Modalities of Relapsed/Refractory Multiple Myeloma Patients in the US: Findings from Preamble

David J Kuter, MD DPhil, Clara Chen, PhD BS, MS, Sergey Popov, Catherine Davis, Ravi Vij, MD MBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 3157.
https://doi.org/10.1182/blood.V130.Suppl_1.3157.3157
Published: 2017
Journal Articles

An Ongoing Multinational Observational Study in Multiple Myeloma (PREAMBLE): Preliminary Report on Patient Survival

Gordon Cook, MD PhD, David Cella, PhD, Brian Durie, MD, Hartmut Goldschmidt, MD, David Kuter, MD DPhil, Philippe Moreau, Ravi Vij, MD MBBS, Catherine Davis, Abderrahim Oukessou, Teresa Zyczynski, PharmD, MPH, MBA, BSPharm, Sergey Popov, Antonio Palumbo, MD
Journal: Blood
Blood (2015) 126 (23): 2093.
https://doi.org/10.1182/blood.V126.23.2093.2093
Published: 2015